Metastatic Triple-Negative Breast Cancer

Welcome to the Metastatic Triple-Negative Breast Cancer Resource Center! Our goal is to provide current information, news, literature, and other resources in this important area of oncology for you and your patients. If you have any feedback or questions, please contact jadpro-editor@broadcastmed.com.

Jacquelyn Lauria, RN, APN, AOCNP
Rutgers Cancer Institute of New Jersey

Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer.

NCCN Guidelines for Patients: Breast Cancer - Invasive

The Landscape of Targeted Therapies in TNBC

Update on Triple-Negative Breast Cancer Disparities for the United States: A Population-Based Study From the United States Cancer Statistics Database, 2010 Through 2014

Metastatic Triple-Negative Breast Cancer Resource Center

Interview with Valerie Shander, MSN, BSN, FNP, RN, AOCNP, CGRA. Clinical Trials and Pressing Clinical Questions in mTNBC

Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer.

NCCN Guidelines for Patients: Breast Cancer - Invasive

The Landscape of Targeted Therapies in TNBC

Update on Triple-Negative Breast Cancer Disparities for the United States: A Population-Based Study From the United States Cancer Statistics Database, 2010 Through 2014

Triple Negative Breast Cancer Molecular Subtyping and Treatment Progress

European Journal of Cancer

Real-world clinical and survival outcomes of patients with early relapsed triple-negative breast cancer from the ESME national cohort

Breast Cancer Research and Treatment

Investigating potential immune mechanisms of trilaciclib administered prior to chemotherapy in patients with metastatic triple-negative breast cancer

Critical Reviews in Oncology/Hematology

Advancing the PD-L1 CPS test in metastatic TNBC: Insights from pathologists and findings from a nationwide survey

Breast Cancer: Basic and Clinical Research

Implementation of risk-stratified breast cancer prevention with a polygenic risk score test in clinical practice

The ASCO Post

Current management of and future possibilities for triple negative breast cancer

Breast Cancer: Basic and Clinical Research

Real-world survival and treatment regimens across first- to third-line treatment for advanced triple-negative breast cancer

Therapeutic Advances in Medical Oncology

Safety and effectiveness of sacituzumab govitecan in patients with metastatic triple-negative breast cancer in real-world settings: First observations from an interdisciplinary breast cancer centre in Germany

Expert Review of Anticancer Therapy

The role of immune checkpoint inhibition in triple negative breast cancer

Cancers

Role of cardiac biomarkers in cancer patients

JAMA Network Open

Risk prediction models for cardiotoxicity of chemotherapy among patients with breast cancer: A systematic review

Patient With Lung Metastasis and HER2-Low Status: Evolving Treatment Options

Treatment of a Patient With AML and mTNBC

Fast Facts #6: Immunotherapy and Endocrinopathies